Comments
Loading...

Viracta Therapeutics (VIRX) Stock Price, Quote, News & History

VIRXOTC
Logo brought to you by Benzinga Data
At close: Feb 13, 4:00 PM EST
$0.0168
-0.0610-78.41%
After Hours: Apr 14, 8:00 AM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Rating and Forecast

12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / -
Day Range
- - -
52 Wk Range
0.01 - 0.26
Market Cap
$388.70K
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therap...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VIRX

FAQ

Q

How do I buy Viracta Therapeutics (VIRX) stock?

A

You can purchase shares of Viracta Therapeutics (OTC:VIRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Viracta Therapeutics (VIRX) competitors?

A

There are no as such competitors for Viracta Therapeutics.

Q

What is the forecast, or price target, for Viracta Therapeutics (VIRX) stock?

A

Viracta Therapeutics has a consensus price target of $5.04.

Q

What is the current price for Viracta Therapeutics (VIRX)?

A

The stock price for Viracta Therapeutics (OTC: VIRX) is $0.00978 last updated July 16, 2025 at 3:40 PM EDT.

Q

Does Viracta Therapeutics (VIRX) pay a dividend?

A

There are no upcoming dividends for Viracta Therapeutics.

Q

When is Viracta Therapeutics (OTC:VIRX) reporting earnings?

A

Viracta Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Q

Is Viracta Therapeutics (VIRX) going to split?

A

There is no upcoming split for Viracta Therapeutics.

Q

What sector and industry does Viracta Therapeutics (VIRX) operate in?

A

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTC.